Literature DB >> 24832032

Is neuropsychological rehabilitation effective in multiple sclerosis?

Päivi Hämäläinen1, Eija Rosti-Otajärvi.   

Abstract

Cognitive deficits are common symptoms in multiple sclerosis (MS), and evident even in the early stages of the disease. Cognitive functions most frequently affected are information processing, memory and learning, and attention. Deficits may have a multidimensional impact on quality of life by weakening the ability to work, impairing social functioning and increasing the strain of the caregiver. To date, no effective pharmacological treatment for cognitive decline has been established, although there is some evidence suggesting that disease-modifying therapies may help to preserve cognitive function. Neuropsychological rehabilitation aims at alleviation of the negative effects of cognitive impairments and has been found to be effective in patients with stroke and traumatic brain injury. This paper discusses the evidence on neuropsychological rehabilitation in MS based on a recent systematic literature review and suggests a model for alleviating the effects of cognitive impairments in MS. The preliminary research evidence on the effects of neuropsychological rehabilitation in MS is positive: rehabilitation may have favorable effects on patients' cognitive performance and coping with cognitive impairments. In clinical practice, the diagnostics and treatment of cognitive impairments should be improved. Neuropsychological rehabilitation should be an important part of a rehabilitation regimen in MS.

Entities:  

Mesh:

Year:  2014        PMID: 24832032     DOI: 10.2217/nmt.14.8

Source DB:  PubMed          Journal:  Neurodegener Dis Manag        ISSN: 1758-2024


  5 in total

1.  Factors Associated with Employment Status in Individuals with Multiple Sclerosis.

Authors:  Margaret Cadden; Peter Arnett
Journal:  Int J MS Care       Date:  2015 Nov-Dec

2.  Validation of the Finnish version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) and evaluation of the applicability of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) and the Fatigue Scale for Motor and Cognitive Functions (FSMC).

Authors:  Päivi Hämäläinen; Vera Leo; Sebastian Therman; Juhani Ruutiainen
Journal:  Brain Behav       Date:  2021-05-07       Impact factor: 2.708

Review 3.  Neurorehabilitation for Multiple Sclerosis Patients with Emotional Dysfunctions.

Authors:  Yuwen Hung; Pavel Yarmak
Journal:  Front Neurol       Date:  2016-01-25       Impact factor: 4.003

4.  Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.

Authors:  Flavia Mattioli; Fabio Bellomi; Chiara Stampatori; Leandro Provinciali; Laura Compagnucci; Antonio Uccelli; Matteo Pardini; Giuseppe Santuccio; Giuditta Fregonese; Marianna Pattini; Beatrice Allegri; Raffaella Clerici; Annalisa Lattuada; Cristina Montomoli; Barbara Corso; Paolo Gallo; Alice Riccardi; Angelo Ghezzi; Marco Roscio; Maria Rosaria Tola; Chiara Calanca; Daria Baldini; Debora Trafficante; Ruggero Capra
Journal:  Front Behav Neurosci       Date:  2016-02-23       Impact factor: 3.558

Review 5.  Cognition in multiple sclerosis: State of the field and priorities for the future.

Authors:  James F Sumowski; Ralph Benedict; Christian Enzinger; Massimo Filippi; Jeroen J Geurts; Paivi Hamalainen; Hanneke Hulst; Matilde Inglese; Victoria M Leavitt; Maria A Rocca; Eija M Rosti-Otajarvi; Stephen Rao
Journal:  Neurology       Date:  2018-01-17       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.